Specialised Therapeutics Expands Opzelura Partnership in Australia
Singapore, September 21, 2026 Specialised Therapeutics (ST) has expanded its existing partnership with Incyte to include ruxolitinib cream (Opzelura®)...
Drug Commercialization
Advertisement
FDA Approves Zanvastro as First Alexander Disease Drug
Silver Spring, Maryland, USA, September 3, 2026 The U.S. Food and Drug Administration (FDA) has approved Zanvastro (zilganersen) injection...
Cipla Partners with Qilu on Keytruda Biosimilar
Mumbai, India and Warren, New Jersey, USA, September 3, 2026 Cipla Limited, through its wholly owned subsidiary InvaGen Pharmaceuticals...
Gan & Lee and Menarini Advance Bofanglutide in Europe
Beijing, China & Florence, Italy, September 3, 2026 Gan & Lee Pharmaceuticals and The Menarini Group have entered into...
Gossamer Bio Reacquires Global Rights to Seralutinib
San Diego, California, July 27, 2026 Gossamer Bio, Inc. announced a series of significant regulatory, strategic, and financial milestones...
Advertisements
Talicia U.S. Commercialization Launch Expands Reach
February 25, 2026 – Raleigh, North Carolina & Tel-Aviv, Israel RedHill Biopharma Ltd. has announced the full operational and...
Advertisement
